Accelerating Product Release Through Patent-Pending RapidCert Biological Indicator (BI) Sterility Testing

In this webinar, you’ll learn about a new fast-tracked, instrument-based biological indicator sterility test — and test service — designed for medical device and pharmaceutical manufacturers. It's called RapidCert, and it offers a transformative approach to biological indicator testing, delivering faster results than traditional compendial methods while upholding product quality and patient safety.

This presentation will outline how the test satisfies regulatory expectations for alternative microbiological methods. It will also highlight key benefits in areas, which include reduced time-to-result, enhanced process control, and improved decision-making.